Direct data capture a game changer for trials: Clinical Ink By Jenni Spinner An executive from the clinical trial technology provider will share how direct data capture can save time, avoid errors and improve the patient experience.
Jonathan Andrus (JA), chief business officer with Clinical Ink, will be presenting eSource Direct Data Capture: Making Virtual Your Reality on Thursday, March 4 at 10:30 am EST. He shared a preview of the session, his perspectives after a quarter century in the industry, and what the future might bring for trial data management.
OSP: Could you please share an overview of how the process of collecting patient data has evolved in recent years?
/Virtual Clinical Trials Market to Register Substantial Expansion by 2026 & Leading Companies like ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable Trending
Virtual Clinical Trials Market to Register Substantial Expansion by 2026 & Leading Companies like ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable
Global Virtual Clinical Trials Market Report 2020
reportsintellectFebruary 15, 2021 35
Virtual Clinical Trials Market research report sheds light and focuses on the Virtual Clinical Trials market scope and growth potential. The report is comprised of useful and knowledgeable insights essential for the Virtual Clinical Trials market. Growth dynamics and leading trends and other essential market prospects have been described in order to give the clients a clear and comprehensive idea of the Virtual Clinical Trials market. The report has a detailed forecast and history of the Virtual Clin
RALEIGH – With the global pandemic driving 7% annual growth in life science service companies, Raleigh-based NovaQuest Private Equity is getting in on the action. And it had help from Goldman Sachs in making a new deal.
Goldman Sachs Specialty Lending Group provided the debt financing NovaQuest needed to make the deal in which CoreRX becomes part of the NovaQuest portfolio. The deal was announced early Tuesday.
However, financial terms were not disclosed.
CoreX is a global contract development and manufacturing organization in Clearwater, Fla. It offers preformulation, formulation, analytical and stability, clinical manufacturing, commercial manufacturing, and packaging services.
NovaQuest
The deal comes as the market for life science firms such as several based in the Triangle is forecast to grow to more than $57 billion by 2025, according to a recent report. And that estimate was made before the full scale of the COVID-19 pandemic struck in 2019.
Clinical Ink launches Lunexis ePRO+ platform module The clinical trial tech firm has enhanced its electronic patient-reported outcome module, and landed an investment to help promote various technologies.
Clinical Ink has announced enhancements to its Lunexis ePRO+ electronic patient-reported outcome module. The module is part of the company’s unified trial technology platform, which reportedly helps streamline implementation and gives both patients and sites the ability to choose which devices they use to participate in a study: smartphone, tablet or web.
“P
atients benefit when they can choose how to participate in a clinical trial – to the extent permitted by the protocol,” Ed Seguine, Clinical Ink CEO, told Outsourcing-Pharma. “